Concepedia

Chongjuan Wei

CW

Statistics

Publications

30

Citations

1.8K

H-Index

19

Active since

1999

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Cancer Genetics (United States)

Chinese Academy of Sciences

Institute of Microbiology

Children's Cancer Center

Chongjuan Wei is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and tumor biology.

Top concepts

Publications per year

1999–2021

30

Publications

30

Ibrutinib and Venetoclax for First-Line Treatment of CLL

Nitin Jain, Michael J. Keating, Philip A. Thompson et al. · New England Journal of Medicine · 2019 · 491 citations · Full text

A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway

Morvarid Mohseni, Jianlong Sun, Allison N. Lau et al. · Nature Cell Biology · 2013 · 288 citations · Full text

, , +9

Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress

Chaofeng Yang, Weiqin Lu, Tao Lin et al. · BMC Gastroenterology · 2013 · 116 citations · Full text

Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia

Nitin Jain, Michael J. Keating, Philip A. Thompson et al. · JAMA Oncology · 2021 · 108 citations · Full text

Suppression of Peutz-Jeghers Polyposis by Targeting Mammalian Target of Rapamycin Signaling

Chongjuan Wei, Christopher I. Amos, Nianxiang Zhang et al. · Clinical Cancer Research · 2008 · 71 citations

Rows per page

1–5 of 30